316 related articles for article (PubMed ID: 25828310)
41. Transcutaneous vagus nerve stimulation in tinnitus: a pilot study.
Lehtimäki J; Hyvärinen P; Ylikoski M; Bergholm M; Mäkelä JP; Aarnisalo A; Pirvola U; Mäkitie A; Ylikoski J
Acta Otolaryngol; 2013 Apr; 133(4):378-82. PubMed ID: 23237096
[TBL] [Abstract][Full Text] [Related]
42. Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study.
Hasan A; Wolff-Menzler C; Pfeiffer S; Falkai P; Weidinger E; Jobst A; Hoell I; Malchow B; Yeganeh-Doost P; Strube W; Quast S; Müller N; Wobrock T
Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):589-600. PubMed ID: 26210303
[TBL] [Abstract][Full Text] [Related]
43. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis.
Huston JM; Gallowitsch-Puerta M; Ochani M; Ochani K; Yuan R; Rosas-Ballina M; Ashok M; Goldstein RS; Chavan S; Pavlov VA; Metz CN; Yang H; Czura CJ; Wang H; Tracey KJ
Crit Care Med; 2007 Dec; 35(12):2762-8. PubMed ID: 17901837
[TBL] [Abstract][Full Text] [Related]
44. Effects of acute transcutaneous vagus nerve stimulation on emotion recognition in adolescent depression.
Koenig J; Parzer P; Haigis N; Liebemann J; Jung T; Resch F; Kaess M
Psychol Med; 2021 Feb; 51(3):511-520. PubMed ID: 31818339
[TBL] [Abstract][Full Text] [Related]
45. Transcutaneous vagus nerve stimulation does not affect attention to fearful faces in high worriers.
Verkuil B; Burger AM
Behav Res Ther; 2019 Feb; 113():25-31. PubMed ID: 30583233
[TBL] [Abstract][Full Text] [Related]
46. Early cortical biomarkers of longitudinal transcutaneous vagus nerve stimulation treatment success in depression.
Fang J; Egorova N; Rong P; Liu J; Hong Y; Fan Y; Wang X; Wang H; Yu Y; Ma Y; Xu C; Li S; Zhao J; Luo M; Zhu B; Kong J
Neuroimage Clin; 2017; 14():105-111. PubMed ID: 28180068
[TBL] [Abstract][Full Text] [Related]
47. Transcutaneous vagus nerve stimulation for partial onset seizure therapy. A new concept.
Ventureyra EC
Childs Nerv Syst; 2000 Feb; 16(2):101-2. PubMed ID: 10663816
[TBL] [Abstract][Full Text] [Related]
48. Cardiovascular responses to low-level transcutaneous vagus nerve stimulation.
Sinkovec M; Trobec R; Meglic B
Auton Neurosci; 2021 Dec; 236():102851. PubMed ID: 34274638
[TBL] [Abstract][Full Text] [Related]
49. Transcutaneous auricular vagus nerve stimulation enhances learning of novel letter-sound relationships in adults.
Thakkar VJ; Engelhart AS; Khodaparast N; Abadzi H; Centanni TM
Brain Stimul; 2020; 13(6):1813-1820. PubMed ID: 33127581
[TBL] [Abstract][Full Text] [Related]
50. Non-invasive stimulation of vagal afferents reduces gastric frequency.
Teckentrup V; Neubert S; Santiago JCP; Hallschmid M; Walter M; Kroemer NB
Brain Stimul; 2020; 13(2):470-473. PubMed ID: 31884186
[TBL] [Abstract][Full Text] [Related]
51. Transcutaneous Vagus Nerve Stimulation Affects Implicit Spiritual Self-Representations.
Finisguerra A; Crescentini C; Urgesi C
Neuroscience; 2019 Aug; 412():144-159. PubMed ID: 31176701
[TBL] [Abstract][Full Text] [Related]
52. Modulation of Muscle Tone and Sympathovagal Balance in Cervical Dystonia Using Percutaneous Stimulation of the Auricular Vagus Nerve.
Kampusch S; Kaniusas E; Széles JC
Artif Organs; 2015 Oct; 39(10):E202-12. PubMed ID: 26450637
[TBL] [Abstract][Full Text] [Related]
53. Reply: Vagal Modulation of Atrial Fibrillation.
Stavrakis S; Humphrey MB; Po SS
J Am Coll Cardiol; 2015 Aug; 66(8):978. PubMed ID: 26293771
[No Abstract] [Full Text] [Related]
54. An alternative therapy for drug-resistant epilepsy: transcutaneous auricular vagus nerve stimulation.
Rong P; Liu A; Zhang J; Wang Y; Yang A; Li L; Ben H; Li L; Liu R; He W; Liu H; Huang F; Li X; Wu P; Zhu B
Chin Med J (Engl); 2014; 127(2):300-4. PubMed ID: 24438620
[TBL] [Abstract][Full Text] [Related]
55. Reinstatement of contextual conditioned anxiety in virtual reality and the effects of transcutaneous vagus nerve stimulation in humans.
Genheimer H; Andreatta M; Asan E; Pauli P
Sci Rep; 2017 Dec; 7(1):17886. PubMed ID: 29263408
[TBL] [Abstract][Full Text] [Related]
56. Looking beyond the ablation shore, treating atrial fibrillation from afar: integrating anatomic, physiologic, neurologic, and cardiovascular principles into novel therapies.
Kapa S; Callans DJ
J Am Coll Cardiol; 2015 Mar; 65(9):876-8. PubMed ID: 25744004
[No Abstract] [Full Text] [Related]
57. Transcutaneous vagus nerve stimulation prevents the development of, and reverses, established oesophageal pain hypersensitivity.
Farmer AD; Albusoda A; Amarasinghe G; Ruffle JK; Fitzke HE; Idrees R; Fried R; Brock C; Aziz Q
Aliment Pharmacol Ther; 2020 Sep; 52(6):988-996. PubMed ID: 32767824
[TBL] [Abstract][Full Text] [Related]
58. Transcutaneous vagal nerve stimulation may elicit anti- and pro-nociceptive effects under experimentally-induced pain - a crossover placebo-controlled investigation.
Laqua R; Leutzow B; Wendt M; Usichenko T
Auton Neurosci; 2014 Oct; 185():120-2. PubMed ID: 25135040
[TBL] [Abstract][Full Text] [Related]
59. The strange case of the ear and the heart: The auricular vagus nerve and its influence on cardiac control.
Murray AR; Atkinson L; Mahadi MK; Deuchars SA; Deuchars J
Auton Neurosci; 2016 Aug; 199():48-53. PubMed ID: 27388046
[TBL] [Abstract][Full Text] [Related]
60. The effect of transcutaneous auricular vagus nerve stimulation on cycling ergometry and recovery in healthy young individuals.
Hatik SH; Asrlan M; Demirbilek Ö; Özden AV
Brain Behav; 2023 Dec; 13(12):e3332. PubMed ID: 37974551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
